Literature DB >> 31129279

Gadoxetate acid disodium-enhanced MRI: Multiple arterial phases using differential sub-sampling with cartesian ordering (DISCO) may achieve more optimal late arterial phases than the single arterial phase imaging.

Yi Wei1, Liping Deng1, Yuan Yuan1, Zixing Huang1, Xiaopeng He1, Xiaocheng Wei2, Hancheng Yang2, Bin Song3.   

Abstract

BACKGROUND: To prospectively determine whether the use of a multiple arterial phase imaging (DISCO) improve the capturing rate of late arterial phase with less motion artifact than single arterial phase obtained with gadoxetate acid disodium.
MATERIALS AND METHODS: From 06/2017 to 10/2018, prospectively acquired data of 132 patients who underwent either single (n = 67) or multiple arterial phase (n = 65) gadoxetate acid-enhanced MR imaging were analyzed. Two readers independently assessed arterial phase timing and the degree of motion artifact using a five-point scale. The kappa test was used to determine the agreement between the two readers, χ2 or fisher exact test were used for the categorical variables and Student t-test or Mann-Whitney U test were used for the comparison of the motion artifacts.
RESULTS: Good to perfect inter-observer agreement was obtained for the arterial phase timing and degree of motion artifact (all kappa value >0.70). Optimal timing of arterial phase was observed in 95.4% (62/65) of multiple arterial phase compared with 73.1% (49/67) of single arterial phase (χ2 = 12.209, p < 0.001). Motion artifact score of the late arterial phase images measured using single arterial phase acquisition (3.22 ± 0.68) was significantly higher than the multiple arterial phase (2.42 ± 0.74) group (t = 5.921, p < 0.001). For the multiple arterial phase comparison, motion artifact score of the 2nd, 3rd and 4th phases were also significant reduced compared with 1st, 5th and 6th phases (all p < 0.05).
CONCLUSION: The use of multiple arterial phase acquisition with gadoxetate acid disodium can improve the capturing rate of well-timed late arterial phase with less motion artifact.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast agents; Hepatocellular carcinoma; Liver; Magnetic resonance imaging

Year:  2019        PMID: 31129279     DOI: 10.1016/j.mri.2019.05.033

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  4 in total

1.  A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma.

Authors:  Yi Wei; Zheng Ye; Yuan Yuan; Zixing Huang; Xiaocheng Wei; Tong Zhang; Shang Wan; Hehan Tang; Xiaopeng He; Bin Song
Journal:  Liver Cancer       Date:  2020-04-14       Impact factor: 11.740

2.  Evaluation of late arterial acquisition and image quality after gadoxetate disodium injection using the CDT-VIBE sequence.

Authors:  Fen Liu; Feng Ma; Guanlan Zhou; Chongtu Yang; Bin Xiong
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

3.  Time resolved DCE-MRI of the kidneys: Evaluation of the renal vasculatures and tumors using F-DISCO with and without compressed sensing in normal and wide-bore 3T systems.

Authors:  Takahiro Yamada; Takayuki Masui; Masako Sasaki; Motoyuki Katayama; Yuji Iwadate; Naoyuki Takei; Mitsuharu Miyoshi
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

4.  Differential Subsampling with Cartesian Ordering Contrast-Enhanced Magnetic Resonance Angiography for the Preoperative Assessment of Anterolateral Thigh Flap.

Authors:  Yunfeng Shen; Xiucun Li; Chao Zhang; Hai Zhong; Weiqiang Dou
Journal:  Korean J Radiol       Date:  2022-06-20       Impact factor: 7.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.